Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

27

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

179689159

Full Text :

https://doi.org/10.1200/JCO.23.02078